Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study
- 1 February 2017
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 71 (2) , 290-298
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- The Danish Register of Causes of DeathScandinavian Journal of Public Health, 2011
- The Danish Civil Registration SystemScandinavian Journal of Public Health, 2011
- A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)Annals of Oncology, 2010
- Randomized Trial Comparing Bleomycin/Etoposide/Cisplatin With Alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin Regimens of Chemotherapy for Patients With Intermediate- and Poor-Risk Metastatic Nonseminomatous Germ Cell Tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MPJournal of Clinical Oncology, 2008
- Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell TumorsJournal of Clinical Oncology, 2007
- Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)Annals of Oncology, 2007
- Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell TumorsJournal of Clinical Oncology, 2007
- Late Relapses of Germ Cell Malignancies: Incidence, Management, and PrognosisJournal of Clinical Oncology, 2006
- Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysisEuropean Journal of Cancer, 2006